NCT00318136 A Study of Bevacizumab Plus Carboplatin and Paclitaxel in Subjects With Advanced, Previously Untreated, Squamous Non-Small Cell Lung Cancer (BRIDGE) Status COMPLETED Phase PHASE2
NCT00317408 Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma Status UNKNOWN Phase NA
NCT00316407 Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer Patients Status COMPLETED Phase PHASE1/PHASE2
NCT00316186 First-line Treatment Of Subjects With Extensive Disease Small Cell Lung Cancer With Weekly Hycamtin And Paraplatin Status COMPLETED Phase PHASE2
NCT00316173 Second-Line Therapy Study For Potentially Platinum-Sensitive Relapsed Ovarian Cancer Status COMPLETED Phase PHASE2
NCT00308750 First Line Chemotherapy Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT00308529 Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00305942 Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00303940 Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors Status COMPLETED Phase PHASE1
NCT00303849 Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT00303810 Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma Status COMPLETED Phase NA
NCT00301782 Combination Chemotherapy in Treating Male Patients With Germ Cell Tumors Status COMPLETED Phase PHASE2
NCT00301028 Cetuximab, Carboplatin, and Paclitaxel Followed by Radiation Therapy, With or Without Cisplatin, in Treating Patients With Metastatic Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00295893 Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT00294931 Irinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00294762 Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC Status COMPLETED Phase PHASE2
NCT00293475 Methotrexate, Mannitol, Rituximab, and Carboplatin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma Status UNKNOWN Phase PHASE1/PHASE2
NCT00293358 Combination Chemotherapy and Radiation Therapy in Treating Patients With Germ Cell Tumors in the Brain Status COMPLETED Phase PHASE3
NCT00293332 Docetaxel, Carboplatin, and Bevacizumab in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery Status TERMINATED Phase PHASE2